December 27, 2024 - 01:19

South Korea's business confidence has experienced its steepest decline since the onset of the Covid-19 pandemic, signaling growing unease among companies about the nation's economic outlook. This downturn is attributed to a combination of political instability and external pressures, particularly the looming threat of tariffs from the United States under the Trump administration.
As businesses navigate these challenges, many are expressing fears about the potential impact on trade and investment. The uncertainty surrounding the global economic environment, coupled with domestic issues, has left executives apprehensive about future growth. This situation has prompted calls for government intervention to stabilize the economy and restore confidence among investors.
Analysts warn that if the trend continues, it could lead to slower economic growth and increased unemployment. The recent decline in confidence underscores the urgent need for strategic measures to address both internal and external factors affecting the South Korean economy.
January 15, 2026 - 22:37
The Evolution of Department Stores: From Essentials to E-commerce ChallengesDepartment stores have undergone a significant transformation over the years, evolving from places that provided essential goods to establishments grappling with the challenges posed by the rise of...
January 15, 2026 - 03:33
From Policy to Paws: The Rise of a Protection Dog BusinessSvalinn has emerged as a notable player in the niche market of family protection dogs, offering a unique blend of companionship and security. Co-founder Kim Greene, previously immersed in the world...
January 14, 2026 - 00:09
Pittsburgh's Mayor Launches Initiative to Revitalize Neighborhood Business DistrictsPittsburgh Mayor Corey O’Connor announced a new initiative aimed at revitalizing neighborhood business districts during a visit to Homewood Avenue in the city`s East End. The initiative, known as...
January 13, 2026 - 03:02
Bristol Myers Squibb Sets Ambitious Goals for New Medicine Launches by 2030San Francisco—Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. CEO Chris Boerner, Ph.D., emphasized that “business development remains a top priority” for...